Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | ($3,996.0M) | ($5,402.0M) | ($6,537.0M) | $9,112.0M | $7,457.0M | ($119.0M) | ($3,328.0M) | ($2,491.0M) | $1,786.0M | $366.0M | $3,709.0M | $8,210.0M | $12.9B | $15.1B | $15.3B | $14.2B | $14.7B | $27.0B | $24.7B | $22.8B |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, AstraZeneca PLC's last 12-month Net Debt is $24.5B, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, AstraZeneca PLC's Net Debt growth was 2.8%. The average annual Net Debt growth rates for AstraZeneca PLC have been 19.7% over the past three years, 11.5% over the past five years.
Over the last year, AstraZeneca PLC's Net Debt growth was 2.8%, which is higher than industry growth of (0.4%). It indicates that AstraZeneca PLC's Net Debt growth is Bad.